ACADIA Pharmaceuticals ACAD
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$36.06M (5 inflow days, 15 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 52.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 5.50% to 4.83% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +618,674 | 5.5% |
| Morgan Stanley | Public Company | 2026/Q3 | +534,048 | 0.9% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +534,048 | 0.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +432,308 | 13.3% |
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +397,834 | 0.9% |
| Y-Intercept (Hong Kong) Limited | Mutual Fund | 2026/Q3 | +382,749 | 0.2% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +340,082 | 0.2% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +313,504 | 0.2% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +274,171 | 0.6% |
| PanAgora Asset Management, Inc. | Mutual Fund | 2026/Q3 | +235,875 | 0.5% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +258,702 | 0.5% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +1,688,651 | 1.0% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +1,559,417 | 1.3% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +1,496,311 | 1.4% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +968,101 | 1.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 29 Oct 2026 | Mark Schneyer | Chief Financial Officer | Automatic Disposition | -3,321 | $20.88 | 71,322 |
| 14 Oct 2026 | Mark Schneyer | Chief Financial Officer | Other Acquisition | +6,815 | – | 71,322 |
| 5 Aug 2026 | Mark Schneyer | Chief Financial Officer | Derivative Exercise and Sale | -20,141 | $29.34 | 67,828 |
| 4 Aug 2026 | Mark Schneyer | Chief Financial Officer | Intent to Sell (Form 144) | -5,849 | $27.15 | – |
| 29 Jul 2026 | Elizabeth H. Thompson | Former Head of Research & Development | Derivative Exercise and Sale | -16,558 | $26.17 | 18,994 |
| 28 Jul 2026 | Elizabeth H. Thompson | Former Head of Research & Development | Derivative Exercise and Retained | +15,714 | – | 18,994 |
| 25 Jun 2026 | James Kihara | Officer | Automatic Disposition | -11,421 | $26.08 | 13,088 |
| 28 May 2026 | Laura Brege | Independent Director | Other Derivative Acquisition | +9,311 | – | 9,311 |
| 28 May 2026 | Laura Brege | Independent Director | Other Derivative Acquisition | +16,004 | $21.66 | 16,004 |
| 28 May 2026 | Laura Brege | Independent Director | Derivative Exercise and Retained | +8,107 | – | 23,202 |
| 28 May 2026 | Julian Baker | Independent Director | Other Derivative Acquisition | +64,016 | $21.66 | 32,008 |
| 28 May 2026 | Edmund Harrigan | Independent Director | Other Derivative Acquisition | +9,311 | – | 9,311 |
| 28 May 2026 | Edmund Harrigan | Independent Director | Other Derivative Acquisition | +16,004 | $21.66 | 16,004 |
| 28 May 2026 | Edmund Harrigan | Independent Director | Derivative Exercise and Retained | +8,107 | – | 43,148 |
| 28 May 2026 | James Daly | Independent Director | Other Derivative Acquisition | +9,311 | – | 9,311 |
| 28 May 2026 | James Daly | Independent Director | Other Derivative Acquisition | +16,004 | $21.66 | 16,004 |
| 28 May 2026 | James Daly | Independent Director | Derivative Exercise and Retained | +8,107 | – | 12,148 |
| 28 May 2026 | Baker Bros. Advisors LP | Other Acquisition | +37,244 | – | 37,244 | |
| 28 May 2026 | Jonathan Poole | Independent Director | Other Derivative Acquisition | +9,311 | – | 9,311 |
| 28 May 2026 | Jonathan Poole | Independent Director | Other Derivative Acquisition | +16,004 | $21.66 | 16,004 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 8,317,392 | 4.8% | 5.9 |
| 15 Oct 2026 | 9,094,151 | 5.3% | 4.6 |
| 30 Sep 2026 | 8,275,918 | 4.8% | 2.9 |
| 15 Sep 2026 | 9,666,972 | 5.6% | 7.2 |
| 31 Aug 2026 | 9,739,720 | 5.7% | 6.9 |
| 14 Aug 2026 | 9,478,912 | 5.5% | 4.5 |
No comments yet — be the first to weigh in on ACAD.
Sign in to join the discussion.